Information about Curoviam
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0818.669.607

VAT liability
No
Established
17-09-2009
Last balance sheet year
2024
Company size
Medium-sized 1 FTE
Principal activity
Activities of banking agents and brokers
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Curoviam

2024 2023 2022 2021
Profit/Loss 63,432 -4 % 66,275 30 % 51,015 -28 % 70,603
Equity 597,911 10 % 544,592 14 % 478,317 12 % 427,302
Gross margin 211,995 7 % 198,450 -1 % 200,074 -1 % 202,413

Publications from Curoviam

Date Publication
07-05-2025 Rubric Restructuring (Fusion, Split, Transfer of Assets, etc...) (FR)
23-11-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Goal - Resignations, Appointments (FR)
12-03-2020 Resignations, Appointments (FR)
12-12-2017 Resignations, Appointments (FR)
19-04-2016 Registered Office (FR)

Frequently asked questions

What is the enterprise number of Curoviam?
The enterprise number of Curoviam is BE 0818.669.607.
Wat is the PEPPOL ID of Curoviam?
There is no information available about the PEPPOL ID of Curoviam or the company is not yet registered on the PEPPOL network.
When was Curoviam founded?
Curoviam was founded on 17-09-2009.
What is the address of Curoviam?
The current registered office of Curoviam is located at Avenue des Cerisiers 85, 1030 Schaerbeek.
When was the last time Curoviam filed their annual financial statements?
The most recent financial statements of Curoviam were filed on 01-10-2025.
How many employees does Curoviam have?
There are 1 FTEs working at Curoviam according to the staff figures in the most recent financial statements.
What is the annual turnover of Curoviam?
At the time of its most recent financial statements, Curoviam did not publish any turnover figures. Curoviam reported a gross margin of €211,995.48.